OpenAlex
PricingAboutJobs
Log inGet started
Work

Glypican-3: A new target for cancer immunotherapy

HTML

Year: 2010
Type: review
Source: European Journal of Cancer
DOI: 10.1016/j.ejca.2010.10.024
Authors: Mitchell Ho, Heungnam Kim
Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research
Language: English

Topic: Proteoglycans and glycosaminoglycans research
Subfield: Cell Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: glypican-3, hepatocellular carcinoma, cancer immunotherapy, therapeutic target, Simpson-Golabi-Behmel syndrome, Wnt signaling, Hedgehog signaling, fibroblast growth factor 2, heparan sulfate, monoclonal antibodies, serum biomarkers, liver cancer
SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, National Institutes of Health, Chugai Pharmaceutical, National Cancer Institute
Awards: Antibody Therapy of Cancer, G6374948078, Development of antibody engineering-based cancer therapies
OpenAlex ID: W1980734717
FWCI: 0.89
Cites: 56
Cited by: 251
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security